News
A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...
A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...
Vaping might be more effective than traditional nicotine replacement therapies in helping people quit smoking, a new study ...
Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...
Because COVID-19 is caused by a virus, antibiotics cannot be used to treat it. However, Pulia says physicians may feel they are erring on the safe side by assuming the patient could also have ...
There will probably never be a perfect treatment to cure COVID-19—but the right medications for the right patients can save lives.
Scientists have identified dozens of human proteins that SARS-CoV-2, the virus that causes COVID-19, depends on to replicate ...
Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...
Invivyd, SPEAR Study Group to assess the effects of monoclonal antibody therapy for recent Covid & Covid-19 post-vaccination syndrome: Waltham, Massachusetts Saturday, July 5, 202 ...
1d
News-Medical.Net on MSNMSU researchers uncover how superfungus Candida auris evades antifungal drugsA groundbreaking study from Michigan State University (MSU), recently published in Nature Communications, has revealed how ...
What Cats May Teach Us About Long COVID - New Cell Therapy Boosts Immune Recovery in Cats With Severe Coronavirus ...
Does colchicine work for CVD or doesn’t it? That’s the question the study authors hoped to answer, but there’s little ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results